Picking the right benzodiazepine based on its metabolism is a critical concept for understanding medication safety, especially when considering hepatic function and drug accumulation. In this episode of This Is Why, Dr. Busti walks through a board-style practice question to break down how different metabolic pathways impact clinical decision-making.

This case highlights how pharmacokinetics directly influences patient outcomes and why recognizing metabolism patterns is essential for safe prescribing.

Topics Covered:

- Benzodiazepine metabolism overview

- Phase 1 vs Phase 2 hepatic drug metabolism

- CYP450 oxidation and active metabolites

- Glucuronidation and drug clearance

- Pharmacokinetics in older adults

- Drug accumulation and prolonged effects

- Clinical decision-making in anxiolytic therapy

- High-yield pharmacology concepts for board preparation

The goal = make medical education easy and clinically relevant.

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#benzodiazepinemetabolism #LOTdrugs #practicequestion #cyp450pharmacology #DrBusti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.